Galena Biopharma - 53 Year Dividend History | SLS
Historical dividend payout and yield for Galena Biopharma (SLS) since 1971. The current TTM dividend payout for Galena Biopharma (SLS) as of April 26, 2024 is $0.00. The current dividend yield for Galena Biopharma as of April 26, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.086B |
$0.001B |
|
SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
